These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Metabolic approach for tumor delineation in glioma surgery: 3D MR spectroscopy image-guided resection. Zhang J; Zhuang DX; Yao CJ; Lin CP; Wang TL; Qin ZY; Wu JS J Neurosurg; 2016 Jun; 124(6):1585-93. PubMed ID: 26636387 [TBL] [Abstract][Full Text] [Related]
3. The Brain Imaging Collaboration Suite (BrICS): A Cloud Platform for Integrating Whole-Brain Spectroscopic MRI into the Radiation Therapy Planning Workflow. Gurbani S; Weinberg B; Cooper L; Mellon E; Schreibmann E; Sheriff S; Maudsley A; Goryawala M; Shu HK; Shim H Tomography; 2019 Mar; 5(1):184-191. PubMed ID: 30854456 [TBL] [Abstract][Full Text] [Related]
4. Association of Radiomics and Metabolic Tumor Volumes in Radiation Treatment of Glioblastoma Multiforme. Lopez CJ; Nagornaya N; Parra NA; Kwon D; Ishkanian F; Markoe AM; Maudsley A; Stoyanova R Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):586-595. PubMed ID: 28011044 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the lactate-to-N-acetyl-aspartate ratio defined with magnetic resonance spectroscopic imaging before radiation therapy as a new predictive marker of the site of relapse in patients with glioblastoma multiforme. Deviers A; Ken S; Filleron T; Rowland B; Laruelo A; Catalaa I; Lubrano V; Celsis P; Berry I; Mogicato G; Cohen-Jonathan Moyal E; Laprie A Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):385-93. PubMed ID: 25104068 [TBL] [Abstract][Full Text] [Related]
6. Multiparametric MR Imaging of Diffusion and Perfusion in Contrast-enhancing and Nonenhancing Components in Patients with Glioblastoma. Boonzaier NR; Larkin TJ; Matys T; van der Hoorn A; Yan JL; Price SJ Radiology; 2017 Jul; 284(1):180-190. PubMed ID: 28240563 [TBL] [Abstract][Full Text] [Related]
7. Accuracy of High-Field Intraoperative MRI in the Detectability of Residual Tumor in Glioma Grade IV Resections. Heßelmann V; Mager AK; Goetz C; Detsch O; Theisgen HK; Friese M; Schwindt W; Gottschalk J; Kremer P Rofo; 2017 Jun; 189(6):519-526. PubMed ID: 28591887 [No Abstract] [Full Text] [Related]
8. Simulating the Effect of Spectroscopic MRI as a Metric for Radiation Therapy Planning in Patients with Glioblastoma. Cordova JS; Kandula S; Gurbani S; Zhong J; Tejani M; Kayode O; Patel K; Prabhu R; Schreibmann E; Crocker I; Holder CA; Shim H; Shu HK Tomography; 2016 Dec; 2(4):366-373. PubMed ID: 28105468 [TBL] [Abstract][Full Text] [Related]
10. Volumetric spectroscopic imaging of glioblastoma multiforme radiation treatment volumes. Parra NA; Maudsley AA; Gupta RK; Ishkanian F; Huang K; Walker GR; Padgett K; Roy B; Panoff J; Markoe A; Stoyanova R Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):376-84. PubMed ID: 25066215 [TBL] [Abstract][Full Text] [Related]
11. Tumor detection with 5-aminolevulinic acid fluorescence and Gd-DTPA-enhanced intraoperative MRI at the border of contrast-enhancing lesions: a prospective study based on histopathological assessment. Coburger J; Engelke J; Scheuerle A; Thal DR; Hlavac M; Wirtz CR; König R Neurosurg Focus; 2014 Feb; 36(2):E3. PubMed ID: 24484256 [TBL] [Abstract][Full Text] [Related]
12. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas. Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781 [TBL] [Abstract][Full Text] [Related]
13. Spectral Radiance of Protoporphyrin IX Fluorescence and Its Histopathological Implications in 5-Aminolevulinic Acid-Guided Surgery for Glioblastoma. Yoneda T; Nonoguchi N; Ikeda N; Yagi R; Kawabata S; Furuse M; Hirose Y; Kuwabara H; Tamura Y; Kajimoto Y; Kuroiwa T Photomed Laser Surg; 2018 May; 36(5):266-272. PubMed ID: 29480754 [TBL] [Abstract][Full Text] [Related]
14. Combining 5-Aminolevulinic Acid Fluorescence and Intraoperative Magnetic Resonance Imaging in Glioblastoma Surgery: A Histology-Based Evaluation. Hauser SB; Kockro RA; Actor B; Sarnthein J; Bernays RL Neurosurgery; 2016 Apr; 78(4):475-83. PubMed ID: 26407129 [TBL] [Abstract][Full Text] [Related]
15. Systematic histopathological analysis of different 5-aminolevulinic acid-induced fluorescence levels in newly diagnosed glioblastomas. Kiesel B; Mischkulnig M; Woehrer A; Martinez-Moreno M; Millesi M; Mallouhi A; Czech T; Preusser M; Hainfellner JA; Wolfsberger S; Knosp E; Widhalm G J Neurosurg; 2018 Aug; 129(2):341-353. PubMed ID: 29076783 [TBL] [Abstract][Full Text] [Related]
16. Relationship between tumor cell infiltration and 5-aminolevulinic acid fluorescence signals after resection of MR-enhancing lesions and its prognostic significance in glioblastoma. Kim J-; Jung T-; Jung S; Kim I-; Jang W-; Moon K-; Kim S-; Kim J-; Lee K- Clin Transl Oncol; 2021 Mar; 23(3):459-467. PubMed ID: 32617871 [TBL] [Abstract][Full Text] [Related]